grant
Development of novel contraceptive methods for men and women
Organization EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTLocation UNITED STATES
NIHUS FederalResearch GrantFY2025AIDS preventionAddressAgreementBiological TestingCRADACharacteristicsChemistryClinicalClinical EvaluationClinical InvestigatorClinical TestingClinical TrialsClinical Trials NetworkContraceptionContraceptive AgentsContraceptive methodsContraceptivesContracting OpportunitiesContractsCooperative Research and Development AgreementCouplesData AnalysesData AnalysisDevelopmentDevelopment and ResearchDevicesDoseDrug DeliveryDrug Delivery SystemsDrugsEvaluationFertility ControlFormulationGelGestationGoalsGood Manufacturing ProcessGood manufacturing practiceHIV InfectionsHIV PreventionHIV/AIDS preventionHTLV-III InfectionsHTLV-III-LAV InfectionsHormonalHumanHuman T-Lymphotropic Virus Type III InfectionsInhibition of FertilizationInjectableInstitutionInternationalInvestigatorsLeadLegal patentMale ContraceptionMale Contraceptive AgentsMale ContraceptivesMediationMedicationMethodsMissionModern ManMultipurpose prevention technologyNICHDNational Institute of Child Health and Human DevelopmentNegotiatingNegotiationPatentsPb elementPharmaceutical PreparationsPhasePregnancyPreparationProgram DevelopmentPublicationsQualifyingR & DR&DRegulatory approvalResearchResearch PersonnelResearchersSafetyScheduleScientific PublicationScientistSiteTechnology TransferTestingToxicologyTrainingTranslatingVaginaVaginal RingWomanchemical synthesisclinical efficacyclinical research siteclinical siteclinical testdata interpretationdesigndesigningdevelopmentaldrug candidatedrug/agentefficacy studyfirst in manfirst-in-humangood laboratory practiceheavy metal Pbheavy metal leadinnovateinnovationinnovativeintravaginal ringmale antifertility drugmanufacturemeetingmeetingsmenmethod developmentmultipurpose preventionnew drug treatmentsnew drugsnew pharmacological therapeuticnew therapeuticsnew therapynext generationnext generation therapeuticsnovelnovel drug treatmentsnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel therapeuticsnovel therapyphase 1 trialphase I trialpre-clinical evaluationpre-clinical studypreclinical evaluationpreclinical studypreparationspreventpreventingprogramsregulatory authorizationregulatory certificationregulatory clearanceresearch and developmentresearch clinical testing
Description preview
CDP uses R&D contracts to achieve the goal of new method development. The Program evaluates new drugs that are not commercially available and must be synthesized under current Good Manufacturing Practice (cGMP) that comply with all regulatory standards of Chemistry, Manufacturing and Controls. CDP maintains a contracted Chemical Synthesis Facility…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click